LENZILUMAB
Dead / Abandoned — Abandoned — after publication (as of 11 Jun 2021)
What this means for you
This application is over — abandoned 11 Jun 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90169030
- Mark type
- Stylized text
- Filed
- 09 Sept 2020
- Published for opposition
- 20 Apr 2021
- Abandoned
- 11 Jun 2021
- Attorney of record
- Jacqueline Zion
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances, namely, antibodies for the treatment of cancer, Immunotherapy-related toxicity, and COVID-19
Owner
- HUMANIGEN, INC., Burlingame, CA, US
- HUMANIGEN, INC., Burlingame, CA, US
Prosecution history
- 11 Jun 2021 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 11 Jun 2021 — ABANDONMENT - AFTER PUBLICATION
- 07 Jun 2021 — TEAS EXPRESS ABANDONMENT RECEIVED
- 18 May 2021 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 20 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Apr 2021 — PUBLISHED FOR OPPOSITION
- 31 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Feb 2021 — ASSIGNED TO EXAMINER
- 15 Oct 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Sept 2020 — NEW APPLICATION ENTERED